The magazine used Securities and Exchange Commission filings, its own reporting and that of its affiliates to compile the rankings.
- Medtronic: $31.7 billion
- Johnson & Johnson MedTech: $27.1 billion
- Siemens Healthineers: $20.5 billion
- Royal Philips: $20.3 billion
- Medline Industries: $20.2 billion
- GE HealthCare: $17.7 billion
- Stryker: $17.1 billion
- Cardinal Health (medical segment): $15.9 billion
- Abbott (medical device segment): $14.4 billion
- Baxter: $12.8 billion
- Henry Schein: $12.4 billion
- Boston Scientific: $11.9 billion
- Owens & Minor: $9.8 billion
- BD (medical segment): $9.5 billion
- B. Braun Melsungen: $9.3 billion
- 3M Co. (healthcare segment): $9.1 billion
- Alcon: $8.2 billion
- Fujifilm Holdings (healthcare only): $7.3 billion
- Zimmer Biomet (minus ZimVie spinoff): $6.8 billion
- Olympus (medical business): $6.7 billion
- Terumo: $6.4 billion
- Intuitive Surgical: $5.7 billion
- Hologic: $5.6 billion
- Edwards Lifesciences: $5.2 billion
- Smith+Nephew: $5.2 billion
- Steris: $4.6 billion
- Fresenius Medical Care (healthcare products): $4.4 billion
- Canon Medical: $4.4 billion
- Dentsply Sirona: $4.3 billion
- BioMérieux: $4 billion
- Align Technology: $4 billion
- Mindray: $3.9 billion
- Hoya (life care segment): $3.7 billion
- Sonova: $3.7 billion
- ResMed: $3.6 billion
- Nipro (medical segment): $3.4 billion
- Getinge: $3.2 billion
- Coloplast: $3 billion
- Demant: $2.9 billion
- Bio-Rad: $2.9 billion
- Cooper Cos.: $2.9 billion
- Teleflex: $2.8 billion
- Paul Hartmann: $2.7 billion
- HU Group: $2.5 billion
- Dexcom: $2.4 billion
- Dräger (medical division): $2.4 billion
- Bruker: $2.4 billion
- Cook Medical: $2.3 billion
- Amplifon: $2.3 billion
- Straumann: $2.2 billion
- ConvaTec: $2 billion
- Carl Zeiss Meditec: $2 billion
- Nihon Kohden: $1.9 billion
- Elekta: $1.7 billion
- Integra Lifesciences: $1.5 billion
- Enovis (formerly Colfax’s medical technology segment, DJO): $1.4 billion
- ICU Medical: $1.3 billion
- Masimo: $1.2 billion
- Cochlear: $1.2 billion
- Integer: $1.2 billion
- Omron Healthcare: $1.2 billion
- Fukuda Denshi: $1.2 billion
- Fisher & Paykel Healthcare: $1.2 billion
- NuVasive: $1.1 billion
- Insulet: $1.1 billion
- Merit Medical Systems: $1 billion
- LivaNova: $1 billion
- Abiomed: $1 billion
- ZimVie (formerly Zimmer Biomet’s spine and dental business): $1 billion
- Conmed: $1 billion
- Konica Minolta (healthcare segment): $1 billion
- Haemonetics: $993.2 million
- Globus Medical: $958.1 million
- Invacare: $872.5 million
- GN Hearing: $849 million
- Cordis: $788 million
- MicroPort: $778.6 million
- Avanos Medical: $744.6 million
- Össur: $719 million
- Asahi Intecc (medical field segment): $667.8 million
- Nikkiso (medical segment): $665.9 million
- Ambu: $613.8 million
- Agfa-Gevaert (radiology solutions segment): $547.5 million
- Novocure: $535 million
- JMS Co.: $529.6 million
- Topcon (eye care business): $520.2 million
- Natus Medical: $473.4 million
- Orthofix: $464.5 million
- Accuray: $429.9 million
- Medacta: $428.5 million
- Nevro: $386.9 million
- iRhythm: $322.8 million
- Barco (healthcare division): $308.6 million
- Artivion (formerly CryoLife): $298.8 million
- Glaukos: $294 million
- Inari Medical: $277 million
- AtriCure: $274.3 million
- Alphatec: $243.2 million
- Shockwave Medical: $237.1 million
- Cardiovascular Systems: $236.2 million